| Literature DB >> 35542186 |
Jianyun Yu1, Chenhui Wang1, Anming Wang1, Ningning Li1, Xinxin Chen1, Xiaolin Pei1, Pengfei Zhang1, Stephen Gang Wu2.
Abstract
To achieve dual-reuse of both enzyme and support in enzyme immobilization, hybrid nanoflowers (hNFs) were synthesized and crystallized in aqueous solution using calcium phosphate as inorganic component and enzyme as organic component. When hNFs lost their catalytic activity after reuse for times, they underwent dissolution and recrystallization to achieve the dual-cycle of enzyme and support. Six enzymes including papain, bromelain, trypsin, Lipase from Porcine Pancreas (PPL), Lipase from Thermomyces lanuginosus (TLL) and Lipase B from Candida antarctica (CALB) were chose as model enzymes and the obtained hNFs all presented high catalytic activity and thermal stability. The highest catalytic efficiency (K cat/K m) of TLL-hNFs was 38.52 mM-1 s-1, 21.7 folds than that of free enzyme. Moreover, after heating for 6 h at 70 °C, the residual activities of TLL-hNFs, PPL-hNFs, and CALB-hNFs, were 78.3%, 72.9% and 84.3%, which were 4.57, 2.61 2.35 folds of that of their corresponding free one. Furthermore, the recovery rate of Ca3(PO4)2 were above 95% by recrystallizing the calcium phosphate with fresh enzymes after dissolving the used hNFs and removing the denatured enzyme. The recrystallized hNFs using the recovered phosphate salts and fresh enzymes all gave the consistent catalytic activities. This sustainable dual-cycle method depending on calcium phosphate crystallization, dissolution and recrystallization, was facile and efficient and can also be applied to other enzymes immobilization for industrial biocatalysis. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35542186 PMCID: PMC9080259 DOI: 10.1039/c8ra02051e
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Scheme for preparing enzyme–Ca3(PO4)2 hybrid nanoflowers crystal.
Fig. 2The process for achieving the cleaner and dual-cycle immobilization for enzyme and support.
Fig. 3SEM images of the hNFs of different enzymes ((A) papain; (B) bromelain; (C) trypsin; (D) TLL; (E) CALB; (F) PPL).
Fig. 4Effect of calcium ion and its concentration on enzymatic activity.
Fig. 5Comparison of catalytic activity between free enzyme with hNFs. (A) Protease; (B) lipase.
Fig. 6Comparison between the hNFs and hNFs after dual-cycle (A) relative activity of hNFs and the hNFs after dual-cycle; (B) recovery rate of Ca3(PO4)2 after dual-cycle.
Fig. 7Thermal stability of free enzyme and enzyme-hNFs preparations ((A) papain; (B) bromelain; (C) trypsin; (D) TLL; (E) CALB; (F) PPL).
The kinetics parameters of free enzyme and hNFs preparations
| Enzyme preparations |
|
|
|
|---|---|---|---|
| Papain | 1.01 ± 0.05 | 2.67 ± 0.01 | 2.67 ± 0.125 |
| Papain-hNFs | 0.7 ± 0.025 | 1.87 ± 0.1 | 2.65 ± 0.452 |
| Bromelain | 0.93 ± 0.04 | 0.38 ± 0.02 | 0.4 ± 0.005 |
| Bromelain-hNFs | 0.46 ± 0.02 | 0.19 ± 0.01 | 0.4 ± 0.13 |
| Trypsin | 0.43 ± 0.022 | 0.5 ± 0.026 | 1.17 ± 0.001 |
| Trypsin-hNFs | 0.07 ± 0.0029 | 0.09 ± 0.004 | 1.27 ± 0.004 |
| TLL | 16.58 ± 0.793 | 29.3 ± 1.265 | 1.77 ± 0.008 |
| TLL-hNFs | 0.17 ± 0.009 | 6.55 ± 0.288 | 38.52 ± 0.347 |
| CALB | 6.36 ± 0.321 | 56.76 ± 2.732 | 8.92 ± 0.023 |
| CALB-hNFs | 0.14 ± 0.007 | 6.14 ± 0.158 | 42.91 ± 1.078 |
| PPL | 0.9 ± 0.046 | 4.44 ± 0.212 | 4.93 ± 0.025 |
| PPL-hNFs | 0.09 ± 0.003 | 5.96 ± 0.278 | 63.36 ± 0.88 |
Fig. 8Protease-hNFs catalytic Knoevenagel condensation.
Synthesis yield of product in Knoevenagel condensation using protease-hNFs as catalystsa
| Entry | Papain-hNFs | Bromelain-hNFs | Trypsin-hNFs |
|---|---|---|---|
| Yield (%) | 28.2 | 23.6 | 25.4 |
Conditions: benzaldehyde (2 mmol), acetylacetone (2.4 mmol), hNFs (150 mg), DI water (1.25 mL), DMSO (3.75 mL) at 60 °C for 24 h.
Yield of the isolated product after purification.
Fig. 9Lipase-hNFs catalytic synthesis of clindamycin palmitate.
Synthesis yield of clindamycin palmitate using lipase-hNFs as catalystsa
| Entry | TLL-hNFs | CALB-hNFs | PPL-hNFs |
|---|---|---|---|
| Yield (%) | 71.9 | 49.1 | 1.6 |
Conditions: clindamycin free base (0.3 mmol), vinyl palmitate (0.9 mmol), petroleum ether (6.25 mL) at 30 °C for 24 h.
Yield of the product detected by HPLC.